Full video transcriptClick to expand
Auto-generated transcript of @trtclinic1's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00injecting testosterone. Using this, not this. This is the modern method. This is the old
- 0:05school method.
Testosterone injection methods compared: what TikTok gets right and wrong
Quick answer
The video appears to compare subcutaneous and intramuscular testosterone injection methods, framing subQ as the modern standard without providing clinical rationale, patient selection criteria, or formulation context. Both injection routes are FDA-recognized delivery methods for testosterone replacement therapy, each with distinct pharmacokinetic profiles and appropriate use cases. A supervised TRT program should determine injection route based on individual patient factors, not perceived novelty.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 6 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Testosterone injection methods compared: what TikTok gets right and wrong, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
Emerging pharmacotherapies for obesity: A systematic review
Broad context for new and established obesity-drug categories.
PubMed
Glucagon-like receptor agonists and next-generation incretin-based medications
Current review for incretin-based obesity medications and cardiometabolic effects.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Testosterone injection methods compared: what TikTok gets right and wrong is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "Testosterone injection methods compared: what TikTok gets right and wrong" from TRT CLINIC. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The video appears to compare subcutaneous and intramuscular testosterone injection methods, framing subQ as the modern standard without providing clinical rationale, patient selection criteria, or formulation context.
The reason this review is not generic is the source wording and the canonical claim label "trt let s compare different methods of injecting testosterone." In this clip, the useful excerpt is: "injecting testosterone." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
The video appears to compare subcutaneous and intramuscular testosterone injection methods, framing subQ as the modern standard without providing clinical rationale, patient selection criteria, or formulation context.
FormBlends verdict
Testosterone evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The video appears to compare subcutaneous and intramuscular testosterone injection methods, framing subQ as the modern standard without providing clinical rationale, patient selection criteria, or formulation context. Both injection routes are FDA-recognized delivery methods for testosterone replacement therapy, each with distinct pharmacokinetic profiles and appropriate use cases. A supervised TRT program should determine injection route based on individual patient factors, not perceived novelty.
- Subcutaneous testosterone injection produces stable serum levels with reduced peak-and-trough variation on frequent dosing schedules, per Olsson et al. (2017, JCEM).
- Intramuscular injection remains the best-studied TRT delivery route and is still appropriate for many clinical protocols, particularly those using longer dosing intervals.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Subcutaneous testosterone injection produces stable serum levels with reduced peak-and-trough variation on frequent dosing schedules, per Olsson et al. (2017, JCEM).
- Intramuscular injection remains the best-studied TRT delivery route and is still appropriate for many clinical protocols, particularly those using longer dosing intervals.
- SubQ absorption can vary meaningfully between individuals, especially in patients with higher body fat percentages, making it unsuitable as a universal recommendation.
- Neither injection route is universally superior. Route selection should be based on testosterone ester, injection frequency, patient body composition, and clinical preference.
- Spratt et al. (2020, Sexual Medicine Reviews) explicitly cautioned against blanket subcutaneous recommendations without individualized patient assessment.
- Changing injection routes without adjusting dose timing or volume can meaningfully shift serum testosterone levels and should only be done under clinical supervision.
- The video's framing of 'modern versus old school' is not a clinical argument. It is a marketing frame that the pharmacology does not support.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @trtclinic1 actually say?
The video is short on words. The creator holds up two syringes and says: "This is the modern method. This is the old school method." That's essentially the entire claim. Without labeling the syringes on screen or naming injection routes, the video implies one delivery method is superior to the other based on its age classification alone. No clinical rationale is offered, no dosing context, no patient profile. The argument is entirely framed around novelty versus tradition, which is a weak basis for any medical comparison.
The most reasonable interpretation, based on standard TRT clinic content, is that the "modern method" refers to subcutaneous (subQ) injection using a short, fine-gauge needle, and the "old school method" refers to intramuscular (IM) injection using a longer needle. That reading shapes the rest of this analysis, though the video itself never confirms it.
Does the science back this up?
Subcutaneous testosterone injection is not fringe science, but calling it definitively "modern" or superior is an oversimplification that the evidence does not fully support. Both routes produce therapeutic testosterone levels in most patients. The real differences are more nuanced than a generational label suggests.
A 2017 study by Olsson et al. in the Journal of Clinical Endocrinology and Metabolism found that subcutaneous testosterone cypionate produced stable serum levels with less peak-and-trough variation compared to standard IM dosing schedules. That is a legitimate advantage. However, a 2021 review by Giltay and colleagues in Andrology noted that IM injection remains the best-studied delivery route for TRT, with decades of pharmacokinetic data, and that subQ absorption can vary more between individuals, particularly in patients with higher body fat percentages. Calling IM "old school" implies it is obsolete. The pharmacology does not support that conclusion.
What did they get wrong (or right)?
Here is what they got right: subcutaneous injection has genuine clinical advantages for many patients. Smaller needle gauge, less injection site discomfort, and more frequent low-dose scheduling that can reduce hormonal swings are all real benefits documented in the literature. Clinicians at TRT-focused practices have increasingly adopted subQ protocols for these reasons, and patient preference data supports it.
Here is what they got wrong: framing this as "modern versus old school" implies IM injection is outdated or inferior by default. That is misleading. IM remains appropriate for certain testosterone esters, specific patient populations, and clinical contexts where absorption consistency is a priority. A 2020 paper by Spratt et al. in Sexual Medicine Reviews specifically cautioned against blanket subQ recommendations without individualized assessment.
The bigger problem is what the video does not say. No information about needle sizes, testosterone ester type, injection frequency, or patient suitability is provided. A viewer who takes "this is the modern method" at face value and attempts to change their own injection technique without clinical guidance could run into real problems, including inconsistent absorption or improper technique.
What should you actually know?
Both intramuscular and subcutaneous testosterone injections are legitimate, clinically used delivery routes with real trade-offs. Neither is universally superior. The right method depends on the specific testosterone formulation being used, the patient's body composition, injection frequency, and personal tolerance for the procedure.
Subcutaneous injection works well with testosterone cypionate and enanthate on frequent low-dose schedules, typically two to three times per week, because the slower subQ absorption complements smaller volumes. Intramuscular injection is still preferred in many clinical protocols, particularly for longer dosing intervals where predictable peak levels matter.
If you are on a TRT program and considering switching injection methods, that conversation belongs with your prescribing clinician, not a TikTok video. Changing your injection route without adjusting dose timing or volume can shift your hormone levels in ways that affect how you feel and your lab results. No 15-second video is sufficient guidance for that decision.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
TRT CLINIC · TikTok creator
1.6K views on this video
Let’s compare different methods of injecting #testosterone
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about subcutaneous testosterone injection produces stable serum levels with reduced peak-and-trough?
Subcutaneous testosterone injection produces stable serum levels with reduced peak-and-trough variation on frequent dosing schedules, per Olsson et al. (2017, JCEM).
What does the video say about intramuscular injection remains the best-studied trt delivery route?
Intramuscular injection remains the best-studied TRT delivery route and is still appropriate for many clinical protocols, particularly those using longer dosing intervals.
What does the video say about subq absorption can vary meaningfully between individuals, especially in patients?
SubQ absorption can vary meaningfully between individuals, especially in patients with higher body fat percentages, making it unsuitable as a universal recommendation.
What does the video say about neither injection route?
Neither injection route is universally superior. Route selection should be based on testosterone ester, injection frequency, patient body composition, and clinical preference.
What does the video say about spratt et al. (2020, sexual medicine reviews) explicitly cautioned against?
Spratt et al. (2020, Sexual Medicine Reviews) explicitly cautioned against blanket subcutaneous recommendations without individualized patient assessment.
What does the video say about changing injection routes without adjusting dose timing?
Changing injection routes without adjusting dose timing or volume can meaningfully shift serum testosterone levels and should only be done under clinical supervision.
Not medical advice. This video was made by TRT CLINIC, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.